Clinical trials
Phase 1 Recurrence trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 10 |
| Terminated | 8 |
| Active, not recruiting | 6 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 8 |
| Amgen | 4 |
| Therapeutic Advances in Childhood Leukemia Consortium | 4 |
| Celgene | 2 |
| MedImmune LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Peter MacCallum Cancer Centre, Australia | 2 |
| Treeline Biosciences, Inc. | 2 |
| Allotera Therapeutics | 1 |
| Arvinas Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 45 |
| Multiple Myeloma | 12 |
| Leukemia | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Neoplasms | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.